A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers

Oncolytic viruses (OVs) are promising anticancer agents but like other cancer monotherapies, the genetic heterogeneity of human malignancies can lead to treatment resistance. We used a virus/cell-based assay to screen diverse chemical libraries to identify small molecules that could act in synergy w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Diallo, Jean-Simon, Boeuf, Fabrice Le, Lai, Frances, Cox, Julie, Vaha-Koskela, Markus, Abdelbary, Hesham, MacTavish, Heather, Waite, Katherine, Falls, Theresa, Wang, Jenny, Brown, Ryan, Blanchard, Jan E, Brown, Eric D, Kirn, David H, Hiscott, John, Atkins, Harry, Lichty, Brian D, Bell, John C
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group 2010
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2889739/
https://ncbi.nlm.nih.gov/pubmed/20389287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2010.67
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires